Stephy
Publishers
Journal of Pediatrics and Clinical Neonatology - (JPCN)
Evaluation
of Serum Tumor Markers Variation, following the Radioactive Iodine Therapy in
Patients with Differentiated Thyroid Cancer
45 cases
of female patients aged 16-60 years with thyroid cancer surgery referred to the
nuclear medicine department of Nemazi hospital for (iodine treatment after
surgery) were selected. The selection was on the basis of interviewing and
information of patients is consent forms. Only patients with thyroid cancer and
referred for the first time without any other diseases were chosen for this
study. The selected patients were prescribed a dose of 150mCi of I-131.From
each patient, 4 mL of chelated serum for serological studies on tumor markers
and 2 mL of oxalated serum for spectrophotometry studies on cell death were
used in three stages. The first stage before the iodine therapy, the second
stage, after 48 hours, and the third stage, 30 days after radioiodine therapy
were studied and the results were evaluated by the one-way repeated measures ANOVA
test.
https://www.stephypublishers.com/pediatrics-and-neonatology/pdf/JPCN.MS.ID.000503.pdf
No comments:
Post a Comment